J Korean Acad Fundam Nurs.  2018 Nov;25(4):293-300. 10.7739/jkafn.2018.25.4.293.

Nurses' Compliance with Safety Guidelines for the Use of Antineoplastic Agents, Observable Symptoms, and Stress from Occupational Exposure

Affiliations
  • 1Department of Nursing, Dongnam Inst. of Radiological · Medical Scienses, Busan, Korea.
  • 2College of Nursing, Catholic University of Pusan, Busan, Korea. hjkim@cup.ac.kr

Abstract

PURPOSE
This study was done to identify the relationship between nurses' compliance with safety guidelines for the use of antineoplastic agents, observable symptoms, and stress from occupational exposure.
METHODS
The participants were 172 nurses from six general hospitals in a metropolitan area. They had administered antineoplastic agents at least three months prior to the study. Data were collected using self-report questionnaires, and then analyzed using SPSS/WIN 23.0 for descriptive statistics, t-test, one-way ANOVA, Scheffé method, and Pearson correlation coefficient.
RESULTS
The average score on the guideline for safety compliance was 87.75 points out of a total of 100. The average score for observable symptoms of exposure to antineoplastic agents was 30.12 (28~56) points, and that for mean stress was 33.52 (15~60) points. Observable symptoms and stress from occupational exposure showed a statistically significant positive correlation (r=0.34, p < .001).
CONCLUSION
To increase the degree of compliance with safety guidelines for antineoplastic agents, hospitals should lower the chance of exposure to antineoplastic agents, as well as minimize the observable symptoms and stress from occupational exposure. Periodic education and policy support are needed to improve compliance with safety guidelines for antineoplastic agent use.

Keyword

Antineoplastic agents; Safety; Compliance; Symptoms; Stress

MeSH Terms

Antineoplastic Agents*
Compliance*
Education
Hospitals, General
Methods
Occupational Exposure*
Antineoplastic Agents
Full Text Links
  • JKAFN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr